Abstract We have cloned and analysed a laeA gene (Pci-laeA) that may control mevastatin biosynthesis in Penicillium citrinum. The full-length Pci-laeA sequence is 1,340 bp with an ORF of 1,284 bp encoding 427 amino acids. It shows 95% identity with LaeA from P. chrysogenum. The predicted molecular mass of Pci-LaeA is 48.72 kDa with an estimated theoretical isoelectric point of 6.96. Pci-LaeA has a conserved S-adenosylmethionine binding site and a potential MlcR (a pathway specific regulator in mevastatin biosynthesis) binding site.
Introduction
Mevastatin (compactin), the first potent and specific competitive inhibitor of 3-hydroxy-3-methylglutarylcoenzyme A (HMG-CoA) reductase, is a polyketide precursor produced by Penicillium citrinum, and has been used as a substrate for microbial conversion to pravastatin, a widely-used pharmaceutical product for the therapy of hypercholesterolemia (Endo et al. 1976; Park et al. 2003) . The gene cluster responsible for compactin biosynthesis in P. citrinum has been identified (Abe et al. 2002) . Among the genes, mlcR is a pathway-specific zinc cluster transcriptional activator of the compactin biosynthetic genes (Baba et al. 2009 ).
In addition to pathway-specific regulators, fungal secondary metabolite biosynthesis is also regulated by global regulators . LaeA, a global regulator for morphological development and secondary metabolism in filamentous fungi has been identified (Bok and Keller 2004) . In Aspergillus nidulans, where LaeA was first discovered, deletion of laeA resulted in a loss of production of numerous secondary metabolites, such as sterigmatocystin and penicillin (Bok and Keller 2004) . Moreover, the production of several toxins including gliotoxin was regulated by LaeA in Aspergillus fumigatus (Bok et al. 2005) . In Penicillium chrysogenum, LaeA positively regulated penicillin biosynthesis, and also pigmentation and sporulation (Kosalkova et al. 2008) . Therefore, it is important to determine the role of Purpose of work: We have studied LaeA, a novel global regulator of secondary metabolism, which has been discovered in filamentous ascomycetes for its possible involvement in merastatin biosynthesis in Penicillium citrinum.
laeA in the secondary metabolism of the mevastatin producer P. citrinum. In this work, we have identified and characterized a P. citrinum laeA (Pci-laeA) gene encoding a protein very similar to that of Penicillium chrysogenum, A. fumigatus and A. nidulans. The discovery of Pci-laeA will facilitate elucidation of the regulatory mechanisms in mevastatin biosynthesis and contribute to strain improvement and the discovery of novel natural products.
Materials and methods

Strains, media and culture conditions
Penicillium citrinum IMB002, a high-level mevastatin producer, was grown from fresh spores in complex medium (g l -1 : tryptone 10, glucose 50, soybean powder 30, g glycerol 10, NaNO 3 5, MgSO 4 1, pH 6.5) at 25°C for 72 h with shaking at 210 rpm. A subculture of this was then grown in complex mevastatin production medium (CMPM, g l -1 : tryptone 10, glucose 50, soybean powder 35, glycerol 50, NaNO 3 5, MgSO 4 1, bean oil 2.6, pH 6.5) at 25°C with shaking.
Extract of genomic DNA and isolation of total RNA Genomic DNA from Penicillium citrinum was isolated from mycelium grown for 96 h in CMPM medium using the CTAB method. Total RNA was also isolated from mycelium grown for 96 h in CMPM medium using the 'RNA-prep Pure Plant Kit' (Tiangen, China), following the manufacturer's instructions.
RT-PCR and cloning of the internal fragment of P. citrinum laeA cDNA Based on the known amino acid sequences of several LaeA proteins deposited in the NCBI database, the conserved region of the laeA gene was identified by MegAlign program of DNAstar software. Two degenerate primers D1: 5 0 -GARCARGAYCGYCTNGAY WT-3 0 and D2: 5 0 -GCYTGRTAKATRTGMAG-3 0 were synthesized to amplify the internal fragment of P. citrinum laeA cDNA by RT-PCR using the 'Takara RNA PCR Kit' (Takara, Japan), following the manufacturer's instruction.
Cloning of 3 0 end sequences of the laeA using RACE technique To obtain the 3 0 -end sequences of laeA cDNA, the rapid amplification of cDNA ends (RACE) technique was used. The oligonucleotide d(T)18-adaptor reverse primer: 5 0 -TACCGTCGTTCCACTAGTGAT TTCACTATAGGTTTTTTTTTTTTTTTTTT-3 0 was used for the synthesis of the first-strand cDNA. The adaptor reverse primer: 5 0 -TACCGTCGTTCCAC TAGTGATTT-3 0 and the gene-specific primer F1: 5 0 -CCCGTGTTGAGGACAAGGATGGT-3 0 were used for amplification of cDNA. Subsequently, the PCR product was tested by two consecutive nested PCR reactions with the adaptor reverse primer and genespecific primers F2: 5 0 -CTGATTCCCACGAGCAG AAGGTT-3 0 , and with the adaptor reverse primer and gene-specific primers F3: 5 0 -CAGTCGGGTTCTT TCTTGGTCC-3 0 , respectively.
Rapid isolation of 5 0 -flanking region of laeA by TAIL-PCR Cloning of the 5 0 flanking region of laeA was carried out by TAIL-PCR (thermal asymmetric interlaced PCR) technique with some modifications (Liu and Whittier 1995) : (1) 10 mers arbitrary primers AD1: 5 0 -GNANCANAGA-3 0 , AD2: 5 0 -GNANCANAGG-3 0 , AD3: 5 0 -CNGANANGAA-3 0 and AD4: 5 0 -GNACN TNGGA-3 0 were used; (2) 10 low-stringency cycles were deleted; and (3) the tertiary PCR procedure was the same as the secondary TAIL-cycling (15 super cycles) instead of normal cycles. Three gene-specific reverse primers R1: 5 0 -GTCAACACCGACCACG AAGGAAT-3 0 , R2: 5 0 -GATGCTGAAAGACTCGTC GGTAG-3 0 and R3: 5 0 -CAAGAAAGAACCCGACT GAAAGG-3 0 were obtained against the cloned internal fragment of laeA cDNA.
Cloning of the whole P. citrinum laeA gene Assembly of the internal and flanking fragments was carried out to form the full-length sequence of the laeA gene using the SeqMan program of DNAstar software. The primers LAF1: 5 0 -AATATCAAC GGATCCATGTCTTACAGAGAG-3 0 and LAR1: 5 0 -TCACCAGGGAGCTCTTATTCCTCGAGAGG-3 0 were used to amplify the coding region of laeA cDNA.
Bioinformatics analysis of the P. citrinum LaeA sequence
The molecular mass and pI (isoelectric point) of P. citrinum LaeA (Pci-LaeA) protein was determined using ProtParam tools (http://www.expasy.org/tools/ protparam.html). The sequence homology was analyzed by BlastP of NCBI (http://www.ncbi.nlm.nih. gov). The alignment of amino acid sequences was carried out using the ClustalW2 (http://www.ebi.ac. uk/clustalw/). The prediction concerning subcellular localization of the protein was performed using WoLF PSORT software (http://wolfpsort.org/).
Accession number
The full length genomic DNA and cDNA sequences of the Pci-laeA gene were submitted to the GenBank database under the accession numbers GU647101 and GU906782 respectively.
Results and discussion
Cloning and analysis of full length DNA and cDNA of Pci-laeA
Using degenerate primers D1 and D2, a 782-bp cDNA fragment was obtained from P. citrinum by RT-PCR (Fig. 1a) . By 3 0 -RACE and TAIL-PCR technique, we obtained the 3 0 -end fragment (1,136 bp) and a 5 0 -flanking fragment (981 bp) of Pci-laeA (Fig. 1b, c) . The whole laeA gene (1,340 bp) and the encoding gene laeA (1,284 bp) gene were amplified from the genomic DNA and cDNA of P. citrinum by PCR using primers LAF1 and LAR1, respectively (Fig. 1d) . A 56-bp intron spanning nucleotides 390-445 of the Pci-laeA gDNA were identified. Sequences of the 5 0 -and 3 0 -intron splice sites were 'GTATGT' and 'GAACAG' respectively. These concur with the consensus fungal intron splice sequences.
An examination of the laeA nucleotide sequence revealed one putative MlcR binding site 5 0 -ACGG-T TGTCGTGA-TCGG-3 0 that was very similar to the consensus sequence for the MlcR-binding sequence 5 0 -(A/T)CGG-NGTN3-6-TCGG-3 0 (Baba et al. 2009 ). It has been recognised that the mlcR binding sites motif is an asymmetric direct repeat that exists in the mlcA-mlcC, mlcB-mlcD, mlcF-mlcG and mlcH-orf11 intergenic regions, and is essential for the transcriptional activation of mlcA and mlcC in P. citrinum (Baba et al. 2009 ). Other similar studies have revealed that another GAL-4 type pathway transcriptional activator AflR has binding sites in the sterigmatocystin (ST) cluster gene and laeA gene simultaneously in A. nidulans (Fernandes et al. 1998; Bok and Keller 2004) . Overexpression of the A. nidulans laeA upregulated alfR expression, while overexpression of alfR downregulated laeA expression (Bok and Keller 2004) . This implies that there may be a potential mlcR binding site in the P. citrinum laeA gene promoter and a unique interaction between laeA and mevastatin gene regulation.
Characterization of P. citrinum LaeA protein and homology analysis
The Pci-laeA encoded a protein of 427 amino acids with an estimated molecular mass of 48.72 kDa and a theoretical pI of 6.96. The results of sequence 0 -flanking region of laeA by TAIL-PCR using degenerate arbitrary primers AD1-4 and nested gene-specific primers R1-R3. The expected PCR fragment indicated by the arrow is 981 bp in size. No expected PCR product was obtained with the primers AD2/R1-3, AD3/R1-3 and AD4/R1-3. M2, DNA marker (2000, 1000, 750, 500, 250, and 100 bp). d PCR amplification of the whole Pci-laeA genomic DNA and cDNA using primers LAF1 and LAR1. The Pci-laeA genomic DNA is of 1,340 bp, and cDNA is of 1,284 bp. M1, DNA marker (2000, 1500, 1000, 700, and 400 bp) homology analysis indicated that Pci-LaeA showed 95, 61 and 60% identity with LaeA protein of P. chrysogenum, A. fumigatus and A. nidulans, respectively. Alignment of the amino acid sequences of the Pci-LaeA protein revealed a conserved S-adenosylmethionine (SAM) binding motif (Fig. 2b) , component of the 193rd to 200th amino acid residues (-LDLGCGTG-), the 219th and 239th amino acid residues of P. citrinum LaeA protein, normally found in most of the protein methyltransferase (Hamahata et al. 1996) . Although Pci-LaeA contains the same SAM motif in histone methyltransferases and arginine methyltransferases as LaeA protein found in other species, it lacks two other conserved domains (SET domain and a double E loop). Therefore, PciLaeA is possibly a unique protein methyltransferase. This remains to be elucidated through further study.
The Pci-LaeA protein was analyzed using WoLF PSORT software. The analysis showed that it was localized in the nucleus, however it did not contain an obvious nuclear localization signal sequence. This phenomenon has also been observed in the LaeA form A. nidulans which not show the presence of a nuclear localization motif; however the existence of GFP tagging in either the 5 0 -or 3 0 -ends suggested that LaeA should be primarily localized in the nucleus (Bok and Keller 2004) . Due to its nuclear localization and conserved methyltransferase SAM-binding motif, the Pci-LaeA protein should be correlated with a change in chromatin conformation (Bok and Keller 2004) .
The discovery of Pci-LaeA provides an important clue for understanding the secondary metabolism of mevastatin. As demonstrated by transcriptome microarray comparative analysis between wild-type, a LaeA deletion mutant and complemented control strains of A. fumigatus, LaeA modulates the expression of approximate 10% of the genes in A. fumigatus. Furthermore, 13 secondary metabolite clusters including 102 genes are under the control of LaeA (Perrin et al. 2007 ). Overexpression of laeA has been reported to enhance expression of some secondary metabolic gene clusters and consequently increased products formation. For example, there was a 4-to 7- fold increase in lovastatin production when the A. nidulans laeA gene was heterogeneously expressed in the A. terreus (Bok and Keller 2004 ). In addition, over-expression of the PclaeA gene led to a 25% increase in penicillin production in P. chrysogenum (Kosalkova et al. 2008) . Modifications of LaeA have been used to trigger cryptic, new natural products, such as terrequione A (an anti-tumor agent that was not previously known to be produced by A. nidulans) (Bouhired et al. 2007) . Although the function of LaeA has not been well understood, laeA-based genomic mining has already shown strong potential as a strategy for activating silent cryptic biosynthetic gene clusters (Bok et al. 2006; Zerikly and Challis 2009 ). The identification of P. citrinum LaeA will be useful for the improvement of industrial strain and the discovery of novel natural products.
